1. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011;96(7): 1911-30. http: //dx.doi.org/10.1210/jc.2011-0385 [
DOI:10.1210/jc.2011-0385] [
PMID]
2. Fauser BCJM, Tarlatzis BC, Rebar RW, Legro RS, Balen AH, Lobo R, et al. Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril 2012;97(1): 28-38.e25. http: //dx.doi.org/10.1016/j.fertnstert.2011.09.024. [
DOI:10.1016/j.fertnstert.2011.09.024] [
PMID]
3. Bhattacharya SM, Jha A. Association of vitamin D3 deficiency with clinical and biochemical parameters in Indian women with polycystic ovary syndrome. Int J Gynaecol Obstet 2013;123(1): 74-5. http: //dx.doi.org/10.1016/j.ijgo.2013.04.021 [
DOI:10.1016/j.ijgo.2013.04.021] [
PMID]
4. Pellatt L, Hanna L, Brincat M, Galea R, Brain H, Whitehead S, et al. Granulosa cell production of anti-Müllerian hormone is increased in polycystic ovaries. J Clin Endocrinol Metab 2007;92(1): 240-5. http: //dx.doi.org/10.1210/jc.2006-1582 [
DOI:10.1210/jc.2006-1582] [
PMID]
5. Vendola KA, Zhou J, Adesanya OO, Weil SJ, Bondy CA. Androgens stimulate early stages of follicular growth in the primate ovary. J Clin Invest 1998;101(12): 2622-9. http: //dx.doi.org/10.1172/JCI2081 [
DOI:10.1172/JCI2081] [
PMID] [
]
6. Merhi Z, Doswell A, Krebs K, Cipolla M. Vitamin D alters genes involved in follicular development and steroidogenesis in human cumulus granulosa cells. J Clin Endocrinol Metab 2014;99(6): E1137-45. http: //dx.doi.org/10.1210/jc.2013-4161 [
DOI:10.1210/jc.2013-4161] [
PMID] [
]
7. Kim S, Kim JJ, Kim MJ, Han KH, Lee JR, Suh CS, et al. Relationship between serum anti-Mullerian hormone with vitamin D and metabolic syndrome risk factors in late reproductive-age women. Gynecol Endocrinol 2018;34(4): 327-31. http: //dx.doi.org/10.1080/09513590.2017.1397113 [
DOI:10.1080/09513590.2017.1397113] [
PMID]
8. Jukic AM, Wilcox AJ, Weinberg CR, Baird DD, Steiner AZ. 25-Hydroxyvitamin D (25 (OH) D) and biomarkers of ovarian reserve. Vol. 25. New York, NY: Menopause; 2018. http: //doi: 10.1097/gme.0000000000001075 [
DOI:10.1097/GME.0000000000001075] [
PMID] [
]
9. Aramesh S, Alifarja T, Jannesar R, Ghaffari P, Vanda R, Bazarganipour F. Does vitamin D supplementation improve ovarian reserve in women with diminished ovarian reserve and vitamin D deficiency: a before-and-after intervention study. BMC Endocr Disord 2021;21(1): 126. http: //dx.doi.org/10.1186/s12902-021-00786-7 [
DOI:10.1186/s12902-021-00786-7] [
PMID] [
]
10. Wong HYQ, Li HWR, Lam KSL, Tam S, Shek CC, Lee CYV, et al. Independent association of serum vitamin D with anti-Mullerian hormone levels in women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 2018;89(5): 634-41. http: //dx.doi.org/10.1111/cen.13816 [
DOI:10.1111/cen.13816] [
PMID]
11. Bednarska-Czerwińska A, Olszak-Wąsik K, Olejek A, Czerwiński M, Tukiendorf AA. Vitamin D and anti-Müllerian hormone levels in infertility treatment: The change-point problem. Nutrients 2019;11(5): 1053. http: //dx.doi.org/10.3390/nu11051053 [
DOI:10.3390/nu11051053] [
PMID] [
]
12. Liu X, Zhang W, Xu Y, Chu Y, Wang X, Li Q, et al. Effect of vitamin D status on normal fertilization rate following in vitro fertilization. Reprod Biol Endocrinol 2019;17(1): 59. http: //dx.doi.org/10.1186/s12958-019-0500-0 [
DOI:10.1186/s12958-019-0500-0] [
PMID] [
]
13. Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004;19(1): 41-7. http: //dx.doi.org/10.1093/humrep/deh098 [
DOI:10.1093/humrep/deh098] [
PMID]
14. Merhi ZO, Seifer DB, Weedon J, Adeyemi O, Holman S, Anastos K, et al. Circulating vitamin D correlates with serum antimüllerian hormone levels in late-reproductive-aged women: Women's Interagency HIV Study. Fertil Steril 2012;98(1): 228-34. http: //dx.doi.org/10.1016/j.fertnstert.2012.03.029 [
DOI:10.1016/j.fertnstert.2012.03.029] [
PMID] [
]
15. Chang EM, Kim YS, Won HJ, Yoon TK, Lee WS. Association between sex steroids, ovarian reserve, and vitamin D levels in healthy nonobese women. J Clin Endocrinol Metab 2014;99(7): 2526-32. http: //dx.doi.org/10.1210/jc.2013-3873 [
DOI:10.1210/jc.2013-3873] [
PMID]
16. Dennis N, Houghton L, Pankhurst M, Harper M, McLennan I. Acute supplementation with high dose vitamin D3 increases serum anti-müllerian hormone in young women. Nutrients 2017;9(7): 719. http: //dx.doi.org/10.3390/nu9070719 [
DOI:10.3390/nu9070719] [
PMID] [
]
17. Dennis NA, Houghton LA, Jones GT, van Rij AM, Morgan K, McLennan IS. The level of serum anti-Müllerian hormone correlates with vitamin D status in men and women but not in boys. J Clin Endocrinol Metab 2012;97(7): 2450-5. http: //dx.doi.org/10.1210/jc.2012-1213 [
DOI:10.1210/jc.2012-1213] [
PMID]
18. Naderi Z, Kashanian M, Chenari L, Sheikhansari N. Evaluating the effects of administration of 25-hydroxyvitamin D supplement on serum anti-mullerian hormone (AMH) levels in infertile women. Gynecol Endocrinol 2018;34(5): 409-12. http: //dx.doi.org/10.1080/09513590.2017.1410785 [
DOI:10.1080/09513590.2017.1410785] [
PMID]
19. Cappy H, Giacobini P, Pigny P, Bruyneel A, Leroy-Billiard M, Dewailly D. Low vitamin D3 and high anti-Müllerian hormone serum levels in the polycystic ovary syndrome (PCOS): Is there a link? Ann Endocrinol (Paris). Ann Endocrinol (Paris) 2016;77(5): 593-9. http: //dx.doi.org/10.1016/j.ando.2016.02.001 [
DOI:10.1016/j.ando.2016.02.001] [
PMID]
20. Irani M, Minkoff H, Seifer DB, Merhi Z. Vitamin D increases serum levels of the soluble receptor for advanced glycation end products in women with PCOS. J Clin Endocrinol Metab 2014;99(5): E886-90. http: //dx.doi.org/10.1210/jc.2013-4374 [
DOI:10.1210/jc.2013-4374] [
PMID]
21. Dastorani M, Aghadavod E, Mirhosseini N, Foroozanfard F, Zadeh Modarres S, Amiri Siavashani M, et al. The effects of vitamin D supplementation on metabolic profiles and gene expression of insulin and lipid metabolism in infertile polycystic ovary syndrome candidates for in vitro fertilization. Reprod Biol Endocrinol 2018;16(1): 94. http: //dx.doi.org/10.1186/s12958-018-0413-3 [
DOI:10.1186/s12958-018-0413-3] [
PMID] [
]
22. Garg D, Tal R. The role of AMH in the pathophysiology of polycystic ovarian syndrome. Reprod Biomed Online 2016;33(1): 15-28. http: //dx.doi.org/10.1016/j.rbmo.2016.04.007 [
DOI:10.1016/j.rbmo.2016.04.007] [
PMID]
23. Szafarowska M, Dziech E, Kaleta B, Kniotek M, Rogowski A, Segiet - Święcicka A, et al. Anti-Müllerian hormone level is associated with vitamin D receptor polymorphisms in women with polycystic ovary syndrome. J Assist Reprod Genet 2019;36(6): 1281-9. http: //dx.doi.org/10.1007/s10815-019-01472-3 [
DOI:10.1007/s10815-019-01472-3] [
PMID] [
]